Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Franchini, Linda
Zanardi, Raffaella
Gasperini, Mariangela
Perez, Jorge
and
Smeraldi, Enrico
1996.
Fluvoxamine and lithium in long-term treatment of unipolar subjects with high recurrence rate.
Journal of Affective Disorders,
Vol. 38,
Issue. 1,
p.
67.
Zanardi, R.
Franchini, L.
Gasperini, M.
Perez, J.
and
Smeraldi, E.
1996.
P-31 Four-year outcomes for maintenance therapies in unipolar subjects with high probability of recurrence.
European Neuropsychopharmacology,
Vol. 6,
Issue. ,
p.
S20.
Schnyder, Ulrich
and
Koller-Leiser, Annemarie
1996.
A Double-Blind, Multicentre Study of Paroxetine and Maprotiline in Major Depression.
The Canadian Journal of Psychiatry,
Vol. 41,
Issue. 4,
p.
239.
Stokes, Peter E.
and
Holtz, Aliza
1997.
Fluoxetine tenth anniversary update: the progress continues.
Clinical Therapeutics,
Vol. 19,
Issue. 5,
p.
1135.
BURROWS, GRAHAM D.
and
NORMAN, TREVOR
1997.
ANTIDEPRESSANTS: CLINICAL ASPECTS.
Stress Medicine,
Vol. 13,
Issue. 3,
p.
167.
van den Burg, Willem
1998.
De (in)effectiviteit van psychofarmaca.
Dth,
Vol. 18,
Issue. 1,
p.
1.
1998.
Is Full Recovery from Depression Possible: pocketbook.
p.
39.
Forshall, Som
and
Nutt, David J.
1999.
Maintenance pharmacotherapy of unipolar depression.
Psychiatric Bulletin,
Vol. 23,
Issue. 6,
p.
370.
Stevens, Tim
Katona, Cornelius
Manela, Monica
Watkin, Vivienne
and
Livingston, Gill
1999.
Drug treatment of older people with affective disorders in the community: lessons from an attempted clinical trial.
International Journal of Geriatric Psychiatry,
Vol. 14,
Issue. 6,
p.
467.
Franchini, Linda
Gasperini, Mariangela
Zanardi, Raffaella
and
Smeraldi, Enrico
2000.
Four-year follow-up study of sertraline and fluvoxamine in long-term treatment of unipolar subjects with high recurrence rate.
Journal of Affective Disorders,
Vol. 58,
Issue. 3,
p.
233.
Anderson, I. M.
Nutt, D. J.
and
Deakin, J. F. W.
2000.
Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 1993 British Association for Psychopharmacology guidelines.
Journal of Psychopharmacology,
Vol. 14,
Issue. 1,
p.
3.
Emslie, Graham J.
Mayes, Taryn L.
and
Hughes, Carroll W.
2000.
UPDATES IN THE PHARMACOLOGIC TREATMENT OF CHILDHOOD DEPRESSION.
Psychiatric Clinics of North America,
Vol. 23,
Issue. 4,
p.
813.
Nutt, David
2000.
Treatment of depression and concomitant anxiety.
European Neuropsychopharmacology,
Vol. 10,
Issue. ,
p.
S433.
Bourin, Michel
Chue, Pierre
and
Guillon, Yannick
2001.
Paroxetine: A Review.
CNS Drug Reviews,
Vol. 7,
Issue. 1,
p.
25.
Celada, Pau
Puig, M. Victoria
Casanovas, Josep M.
Guillazo, Gemma
and
Artigas, Francesc
2001.
Control of Dorsal Raphe Serotonergic Neurons by the Medial Prefrontal Cortex: Involvement of Serotonin-1A, GABAA, and Glutamate Receptors.
The Journal of Neuroscience,
Vol. 21,
Issue. 24,
p.
9917.
Nuijten, Mark J.C.
2001.
Assessment of Clinical Guidelines for Continuation Treatment in Major Depression.
Value in Health,
Vol. 4,
Issue. 4,
p.
281.
CALEY, CHARLES F.
and
KANDO, JUDITH C.
2002.
SSRI Efficacy—Finding the Right Dose.
Journal of Psychiatric Practice,
Vol. 8,
Issue. 1,
p.
33.
Buchman, Nili
Strous, Rael D.
and
Baruch, Yehuda
2002.
Side Effects of Long-Term Treatment With Fluoxetine.
Clinical Neuropharmacology,
Vol. 25,
Issue. 1,
p.
55.
Celada, Pau
Puig, M. Victoria
Martín-Ruiz, Raúl
Casanovas, Josep M.
and
Artigas, Francesc
2002.
Control of the serotonergic system by the medial prefrontal cortex: Potential role in the etiology of PTSD and depressive disorders.
Neurotoxicity Research,
Vol. 4,
Issue. 5-6,
p.
409.
Weihs, Karen L
Houser, Trisha L
Batey, Sharyn R
Ascher, John A
Bolden-Watson, Carolyn
Donahue, Rafe M.J
and
Metz, Alan
2002.
Continuation phase treatment with bupropion SR effectively decreases the risk for relapse of depression.
Biological Psychiatry,
Vol. 51,
Issue. 9,
p.
753.
eLetters
No eLetters have been published for this article.